[SRNE] YoY Quarter Result on 31-Dec-2012 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
25-Mar-2013
Financial Year
2012
Quarter
31-Dec-2012 [#Q4]
Profit Trend
QoQ- -41.42%
YoY- -130.31%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 1,337 798 101 122 128 512 5 153.71%
PBT -25,413 -10,207 -11,296 -3,236 -3,236 -1,808 -710 81.48%
Tax 1,186 1 4 -3,090 -2,474 -1,620 -138 -
NP -23,476 -8,505 -11,296 -1,755 -762 -188 -686 80.13%
Tax Rate - - - - - - - -
Total Cost 24,813 9,303 11,397 1,877 890 700 691 81.58%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin -1,755.87 -1,065.79 -11,217.68 -1,438.58 -595.84 -36.75 -12,672.10 -28.05%
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
EPS -0.62 -0.23 -0.49 -0.14 -0.07 -0.02 -0.08 40.65%
EPS Diluted -0.62 -0.23 -0.49 -0.14 -0.07 -0.02 -0.08 40.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.